(Q37091554)

English

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer

scientific article published on December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

2

object named as

Kenneth L Gage

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

9

object named as

George Sgouros

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Robert F Dannals

8

object named as

Robert F Dannals

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Barbara S Slusher

15

object named as

Barbara S Slusher

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Martin G. Pomper

17

object named as

Martin G Pomper

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael A. Carducci

13

object named as

Michael A Carducci

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Steve Y Cho

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ronnie C Mease

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Srinivasan Senthamizhchelvan

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Daniel P Holt

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Akimosa Jeffrey-Kwanisai

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Christopher J Endres

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Martin Lodge

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mario A Eisenberger

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ronald Rodriguez

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Camilo Rojas

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Alan P Kozikowski

16

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 December 2012

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The Journal of Nuclear Medicine

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

53

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1883-1891

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

GCPII imaging and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

New therapies for castration-resistant prostate cancer: efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Human Biodistribution and Radiation Dosimetry of 82Rb

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Challenges in clinical prostate cancer: role of imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Skeletal PET with 18F-fluoride: applying new technology to an old tracer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Prostate cancer: a practical approach to current management of recurrent disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

29 September 2017

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

27 June 2018

The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

Method for estimating skeletal spongiosa volume and active marrow mass in the adult male and adult female.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

Physical models and dose factors for use in internal dose assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

Column-switching HPLC for the analysis of plasma in PET imaging studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3742115

3 September 2018

Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose to the Fetus from Radionuclides in the Bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic anatomical and physiological data for use in radiological protection: the skeleton. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of prostate-specific membrane antigen in normal and malignant human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23203246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2967/JNUMED.112.104661

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37091554&oldid=2201564540"